Home > Insider Trading > Filing (0001209191-18-019907)

Filing Details

Accession Number:: 0001209191-18-019907
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-03-15 17:25:54
Reporting Period:: 2018-03-12

Accepted Time:: 2018-03-15 17:25:54
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1020214	Cerus Corp	CERS	Surgical & Medical Instruments & Apparatus (3841)	680262011

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1193209	M Laurence Corash	C/O Cerus Corporation 2550 Stanwell Drive Concord CA 94520	Chief Scientific Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2018-03-12	10,000	$4.95	1,462,580	No	4	P	Direct
Common Stock	Acquisiton	2018-03-13	90,000	$5.13	1,552,580	No	4	P	Direct
Common Stock	Acquisiton	2018-03-14	17,911	$5.19	1,570,491	No	4	P	Direct
Common Stock	Acquisiton	2018-03-15	32,100	$5.27	1,602,591	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

The reported price in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.86 to $4.95 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the aforementioned range set forth.
The reported price in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.03 to $5.17 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the aforementioned range set forth.
The reported price in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.15 to $5.23 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the aforementioned range set forth.
The reported price in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.24 to $5.30 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the aforementioned range set forth.